Literature DB >> 15459597

Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.

Marcin Grabowski1, Krzysztof J Filipiak, Grzegorz Karpinski, Dominik Wretowski, Adam Rdzanek, Zenon Huczek, Grzegorz J Horszczaruk, Janusz Kochman, Robert Rudowski, Grzegorz Opolski.   

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) levels are predictive of short-term death in patients with acute coronary syndromes. Few data are available for BNP levels obtained on admission in patients with acute ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).
METHODS: Blood samples for BNP estimation, obtained on admission in 126 consecutive patients (mean age, 58.8 +/- 10.7 years) with STEMI, were measured at the bedside by using a simple point-of-care test in a 15-minute period before PCI. Follow-up up to 42 days was performed.
RESULTS: A baseline BNP value of 331 pg/mL had a sensitivity of 87.9% and a specificity of 90% for predicting death in a follow-up study. There was no difference in subgroups by median BNP (100 pg/mL) in Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 before PCI, although higher BNP levels were observed among patients with TIMI <3 after PCI than among those with TIMI 3 (356.7 +/- 350.8 vs 144.9 +/- 191.2 pg/mL; P <.0001). In multivariate logistic regression analysis, admission BNP was the independent predictor for the following: death (odds ratio [OR], 16.3; 95% confidence interval [CI], 1.4 to 186.7; P =.03), TIMI grade <3 after PCI (OR, 3.4; 95% CI, 1.2 to 9.6; P =.02), and the no-reflow phenomenon (OR, 6.2; 95% CI, 1.7 to 23; P =.007) after adjusting for other variables.
CONCLUSIONS: BNP levels obtained on admission are a powerful, independent predictor of short-term death and angiographic success after PCI in patients with STEMI. The no-reflow phenomenon may be predicted in STEMI on the basis of high serum BNP values on admission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459597     DOI: 10.1016/j.ahj.2004.04.023

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.

Authors:  Sean van Diepen; Matthew T Roe; Renato D Lopes; Amanda Stebbins; Stefan James; L Kristin Newby; David J Moliterno; Franz-Josef Neumann; Justin A Ezekowitz; Kenneth W Mahaffey; Judith S Hochman; Christian W Hamm; Paul W Armstrong; Pierre Theroux; Christopher B Granger
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 2.  Role of Sam68 as an adaptor protein in signal transduction.

Authors:  S Najib; C Martín-Romero; C González-Yanes; V Sánchez-Margalet
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

3.  Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention.

Authors:  Bin Peng; Hao Xia; Aihua Ni; Gang Wu; Xuejun Jiang
Journal:  Herz       Date:  2015-05-22       Impact factor: 1.443

4.  Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting.

Authors:  Amanda A Fox; Jochen D Muehlschlegel; Simon C Body; Stanton K Shernan; Kuang-Yu Liu; Tjorvi E Perry; Sary F Aranki; E Francis Cook; Edward R Marcantonio; Charles D Collard
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

5.  High BNP level as risk factor for acute kidney injury and predictor of all-cause mortality in STEMI patients.

Authors:  O Akgul; H Uyarel; H Pusuroglu; N Isiksacan; S Turen; M Erturk; O Surgit; O Celik; E Oner; A Birant; I F Akturk; N Uslu
Journal:  Herz       Date:  2014-06       Impact factor: 1.443

6.  Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery.

Authors:  Amanda A Fox; Edward R Marcantonio; Charles D Collard; Mathis Thoma; Tjorvi E Perry; Stanton K Shernan; Jochen D Muehlschlegel; Simon C Body
Journal:  Anesthesiology       Date:  2011-04       Impact factor: 7.892

7.  B-type natriuretic peptide as predictor of heart failure in patients with acute ST elevation myocardial infarction, single-vessel disease, and complete revascularization: follow-up study.

Authors:  Sime Manola; Nikola Pavlović; Vjekoslav Radeljić; Diana Delić Brkljacić; Hrvoje Pintarić; Kresimir Stambuk; Nikola Bulj; Matias Trbusić; Tomislav Krcmar; Ljerka Lukinac
Journal:  Croat Med J       Date:  2009-10       Impact factor: 1.351

8.  Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome.

Authors:  Nilüfer Cifçi; Meral Uyar; Osman Elbek; Hüseyin Süyür; Erhan Ekinci
Journal:  Sleep Breath       Date:  2009-10-08       Impact factor: 2.816

9.  A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.

Authors:  Shuting Kong; Changxi Chen; Gaoshu Zheng; Hui Yao; Junfeng Li; Hong Ye; Xiaobo Wang; Xiang Qu; Xiaodong Zhou; Yucheng Lu; Hao Zhou
Journal:  BMC Cardiovasc Disord       Date:  2021-05-22       Impact factor: 2.298

10.  Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients.

Authors:  Thomas Schachner; Dominik Wiedemann; Hannes Fetz; Guenther Laufer; Alfred Kocher; Nikolaos Bonaros
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.